Responses
Immune cell therapies and immune cell engineering
Original research
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells
Compose a Response to This Article
Other responses
No responses have been published for this article.
